Merck | MRK - Loan Capital


Merck reported EUR10.8B in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Adidas EUR 4.8B 462M Jun/2026
Adyen EUR 183.27M 8.2M Dec/2025
Akzo Nobel EUR 5.5B 743M Jun/2026
Alcon AG USD 4.16B 434M Mar/2026
Amadeus IT EUR 2.54B 2.2M Jun/2026
AstraZeneca USD 26.01B 46M Jun/2026
BASF EUR 18.83B 1.08B Jun/2026
Bayer EUR 30.68B 1.15B Mar/2026
Beiersdorf EUR 117M 15M Dec/2025
Covestro EUR 1.67B 408M Dec/2025
Danone EUR 10.68B 609M Jun/2026
Fresenius EUR 9.55B 1.24B Jun/2026
Fresenius Medical Care EUR 5.74B 895.27M Mar/2026
Genmab DKK 4.96B 28M Jun/2026
Givaudan CHF 4.19B 448M Dec/2025
GlaxoSmithKline GBP 13.95B 65M Jun/2026
GRIFOLS EUR 7.17B 1.91B Jun/2026
Henkel EUR 3.26B 1.88B Jun/2026
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Infineon EUR 6.36B 41M Jun/2026
Lakefront Biotherapeutics EUR 4.85M 335K Mar/2026
Linde USD 19.86B 824M Mar/2026
Lonza CHF 3.88B 323M Dec/2025
Merck EUR 10.8B 72M Mar/2026
Novartis USD 37.49B 42M Jun/2026
Philips EUR 6.32B 575M Jun/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
Sanofi EUR 14.65B 806M Jun/2026
UCB EUR 2.18B 634M Dec/2025